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The neglected global burden of tuberculosis in pregnancy  
Tuberculosis remains a global emergency and continues 
to present major public health challenges worldwide. 
The actual global burden of tuberculosis can only 
be estimated because no accurate data are available 
from national country programmes from of high 
tuberculosis endemic countries. The WHO 2014 annual 
tuberculosis report1 estimates that 3·3 million women 
developed active tuberculosis in 2013, resulting in 
510 000 deaths, 180 000 (35%) in those who were 
HIV-infected. Tuberculosis is one of the top causes of 
death in women of reproductive age and is a common 
non-obstetric cause of maternal mortality.2–6 Untreated, 
tuberculosis in pregnancy can have a mortality of up 
to 40%.5,6 Active tuberculosis disease in HIV-infected 
pregnant women increases the risk of maternal 
mortality by nearly 300%. The exact magnitude of the 
global prevalence of tuberculosis in pregnant women 
remains undeﬁ ned and requires deﬁ nition.
Accurate diagnosis of tuberculosis in pregnancy is 
diﬃ  cult because the symptoms and signs of pregnancy 
overlap with those of tuberculosis and other infectious 
and non-communicable diseases.2–7 Thus, unless there 
is a high degree of clinical awareness and availability 
of tuberculosis diagnostic tests, many cases of active 
tuberculosis in pregnancy are easily missed and remain 
undiagnosed and unreported. WHO estimates that 
3 million active tuberculosis cases are missed annually 
and need to be found,8 and it is probable that large 
numbers of pregnant women with active tuberculosis 
are being missed.
In this issue of The Lancet Global Health, Jordan 
Sugarman and colleagues9 present their analyses of data 
lending further support in terms of further estimates to 
the growing consensus and international concern over 
the long-neglected issue of tuberculosis in pregnancy.1–6 
Using publicly accessible country level estimates 
of demographic and epidemiological parameters 
from 217 countries, they derived estimates of the 
number of pregnant women with active tuberculosis. 
Although they point out the inherent weaknesses of 
their approach, they used indicators of health system 
access and data for performance of diagnostic tests 
to estimate that, globally in 2011, there were 216 500 
(95% uncertainty range 192 100–247 000) pregnant 
women with active tuberculosis, of which the Africa 
(89 400 cases; 41%) and South-East Asia (67 500; 31%) 
WHO regions had the largest numbers. Sugarman and 
colleagues’ assessment of the potential eﬀ ect of several 
tuberculosis diagnostic tests used with diﬀ erent levels 
of health-care access adds further to previous calls2–7 for 
the introduction of proactive screening for tuberculosis 
in pregnant women at whichever health-care facility 
they present, with rapid diagnostic tests to diagnose 
tuberculosis which would otherwise remain undetected 
and untreated. Several important scientiﬁ c and 
operational issues of current health services relating 
to the speciﬁ c issue of tuberculosis in pregnancy arise 
from Sugarman and colleagues’ study, which need to 
be addressed by governments and funders to provide 
optimum tuberculosis care for pregnant women. 
In most countries with high tuberculosis burden, 
the standard recommendations of care for screening 
and diagnosing tuberculosis in pregnant women is the 
same as that used to detect tuberculosis disease in the 
general population. More speciﬁ c focus on tuberculosis 
in pregnancy is required if the undiagnosed tuberculosis 
load is to be reduced. Furthermore, the eﬀ ect of the 
ominous growing global problem of multidrug-resistant 
tuberculosis (MDR-TB) in southern Africa, Asia, and 
eastern Europe on the health of pregnant women 
requires urgent deﬁ nition because it carries a high 
mortality and second-line tuberculosis drugs are toxic 
and not recommended for use in pregnancy. Accurate 
country-speciﬁ c demographic and epidemiological 
data estimates and statistical returns of drug-resistant 
tuberculosis from developing countries with high 
tuberculosis burden will not be available unless the 
existing clinical, laboratory, management, and data 
reporting deﬁ ciencies of health systems are corrected. 
Improving knowledge of tuberculosis and MDR-TB 
amongst antenatal care providers, more proactive 
screening for tuberculosis and MDR-TB, and availability 
and optimum use of new accurate rapid tuberculosis 
diagnostic tests must be coupled with accurate 
recording, collection, and reporting of disease-speciﬁ c 
demographic and epidemiological data. Health-care 
workers providing antenatal care must have knowledge 
of the limitations in making a diagnosis of tuberculosis 
in pregnancy and of the safety proﬁ le of anti-
tuberculosis drugs. The treatment and management of 
See Articles page e710
Comment
e676 www.thelancet.com/lancetgh   Vol 2   December 2014
HIV-infected pregnant women with active tuberculosis 
remains problematic because of pharmacokinetic 
interactions of tuberculosis drugs with antiretrovirals, 
enhanced drug toxicities and side-eﬀ ects, development 
of immune reconstitution inﬂ ammatory syndrome, and 
high pill burden and adherence issues.
Several communicable and non-communicable 
diseases in pregnancy can adversely aﬀ ect maternal and 
child health and are associated with increased morbidity 
and mortality.10 Recent trends show that many health 
programmes do not deliver good quality tuberculosis 
and HIV services because of inadequately trained 
clinical and laboratory staﬀ , and ill equipped health 
facilities.11,12 Governmental commitment is urgently 
required to align maternal and child health services 
synergistically to the current silos of tuberculosis, HIV, 
malaria, and maternal child health programmes. Ideally 
this should focus on the scale-up and integration of 
health services that will generically address all maternal 
health concerns related to both communicable and non-
communicable diseases, such as HIV, malaria, respiratory 
tract infections, parasitic infestations, diabetes, 
hypertension, anaemia, and vitamin deﬁ ciencies. 
Routine antenatal care presents a unique opportunity 
for detection, evaluation, and management of a range 
of communicable and non-communicable diseases in 
pregnant women.
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